|
1.
|
|
10 p, 1.4 MB |
Cardiac and pulmonary findings in dysferlinopathy : A 3-year, longitudinal study
/
Moore, Ursula (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Fernandez-Torron, Roberto (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
Jacobs, Marni (Pediatrics. Epidemiology and Biostatistics. George Washington University) ;
Gordish-Dressman, Heather (Pediatrics. Epidemiology and Biostatistics. George Washington University) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
James, Meredith K (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Mayhew, Anna G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Harris, Elizabeth (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Guglieri, Michela (Newcastle University) ;
Rufibach, Laura E. (The Jain Foundation) ;
Feng, Jia (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Blamire, Andrew (Translational and Clinical Research Institute. Newcastle University) ;
Carlier, Pierre G. (University Paris-Saclay. CEA. DRF. Service Hospitalier Frederic Joliot) ;
Spuler, Simone (Charite Muscle Research Unit. Experimental and Clinical Research Center. a joint cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W (Stanford University School of Medicine) ;
Jones, Kristi J. (The Children's Hospital at Westmead. and The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (Service des maladies neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Stojkovic, Tanya (Sorbonne Université) ;
Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Pegoraro, Elena (Department of Neuroscience. University of Padova) ;
Lowes, Linda Pax (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Mendell, Jerery R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Bushby, Kate (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Bourke, John (Department of Cardiology. Freeman Hospital. NUTH NHS Hospitals Foundation Trust) ;
Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust)
Introduction/Aims: There is debate about whether and to what extent either respiratory or cardiac dysfunction occurs in patients with dysferlinopathy. This study aimed to establish definitively whether dysfunction in either system is part of the dysferlinopathy phenotype. [...]
2022 -  10.1002/mus.27524
Muscle & nerve, Vol. 65 Núm. 5 (may 2022) , p. 531-540
|
|
|
2.
|
|
10 p, 585.1 KB |
Water T2 could predict functional decline in patients with dysferlinopathy
/
Moore, Ursula. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Caldas de A. Araújo, Ericky (NMR Laboratory. CEA/DRF/IBFJ/MIRCen) ;
Reyngoudt, Harmen (NMR Laboratory. CEA/DRF/IBFJ/MIRCen) ;
Gordish-Dressman, Heather (Pediatrics. Epidemiology and Biostatistics. George Washington University) ;
Smith, Fiona E. (Magnetic Resonance Centre. Translational and Clinical Research Institute. Newcastle University) ;
Wilson, Ian (Magnetic Resonance Centre. Translational and Clinical Research Institute. Newcastle University) ;
James, Meredith (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Mayhew, Anna (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Rufibach, Laura (Jain Foundation) ;
Day, John W. (Department of Neurology and Neurological Sciences. Stanford University School of Medicine) ;
Jones, Kristi J. (The Children's Hospital at Westmead and The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (Service des maladies neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Stojkovic, Tanya (Centre de référence des maladies neuromusculaires. Institut de Myologie. AP-HP. Sorbonne Université. Hôpital Pitié-Salpêtrière) ;
Mori-Yoshimura, Madoka (Department of Neurology. National Center Hospital. National Center of Neurology and Psychiatry) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Pegoraro, Elena (Department of Neuroscience. University of Padova) ;
Mendell, Jerry R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Bushby, Kate (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Blamire, Andrew (Magnetic Resonance Centre. Translational and Clinical Research Institute. Newcastle University) ;
Straub, Volker (Newcastle University) ;
Carlier, Pierre G. (Université Paris-Saclay. CEA. DRF. Service Hospitalier Frederic Joliot) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Background: Water T2 (T2) mapping is increasingly being used in muscular dystrophies to assess active muscle damage. It has been suggested as a surrogate outcome measure for clinical trials. Here, we investigated the prognostic utility of T2 to identify changes in muscle function over time in limb girdle muscular dystrophies. [...]
2022 - 10.1002/jcsm.13063
Journal of Cachexia, Sarcopenia and Muscle, Vol. 13 Núm. 6 (december 2022) , p. 2888-2897
|
|
|
3.
|
|
10 p, 1.7 MB |
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy : A Rasch Analysis Approach
/
Mayhew, Anna G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
James, Meredith K. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Moore, Ursula (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Sutherland, Helen (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Jacobs, Marni (Pediatrics. Epidemiology and Biostatistics. George Washington University) ;
Feng, Jia (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Lowes, Linda Pax (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Alfano, Lindsay N. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Muni Lofra, Robert (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Rufibach, Laura E. (The Jain Foundation) ;
Rose, Kristy (The Children's Hospital at Westmead. The University of Sydney) ;
Duong, Tina (Lucile Salter Packard Children's Hospital at Stanford. Neurology) ;
Bello, Luca (Department of Neuroscience. University of Padova) ;
Pedrosa-Hernández, Irene (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Holsten, S. (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Sakamoto, C. (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry Tokyo) ;
Canal, Aurélie (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Sánchez-Aguilera Práxedes, N. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Thiele, S. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians-University of Munich) ;
Siener, C. (Department of Neurology. Washington University School of Medicine) ;
Vandevelde, B. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
DeWolf, Brittney (Cooperative International Neuromuscular Research Group. Children's National Health System) ;
Maron, E. (ELAN-PHYSIO. Praxis für Physiotherapie Maron) ;
Gordish-Dressman, H. (Pediatrics. Epidemiology and Biostatistics. George Washington University) ;
Hilsden, H. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Guglieri, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Hogrel, J.Y. (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Blamire, Andrew (Magnetic Resonance Centre. Institute for Cellular Medicine. Newcastle University) ;
Carlier, Pierre G. (Pitié-Salpêtrière University Hospital) ;
Spuler, S. (Charite Muscle Research Unit. Experimental and Clinical Research Center. A Joint Cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W. (Stanford University School of Medicine) ;
Jones, K.J. (The Children's Hospital at Westmead. The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, E. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, M.C. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians-University of Munich) ;
Paradas, C. (Instituto de Biomedicina de Sevilla) ;
Stojkovic, T. (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Pegoraro, Elena (University of Padova) ;
Mendell, J. R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Jain COS Consortium, None (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Straub, V. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust)
Dysferlinopathy is a muscular dystrophy with a highly variable functional disease progression in which the relationship of function to some patient reported outcome measures (PROMs) has not been previously reported. [...]
2022 - 10.3389/fneur.2022.828525
Frontiers in neurology, Vol. 13 (october 2022) , p. 828525
|
|
|
4.
|
|
16 p, 4.6 MB |
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease
/
Moore, Ursula (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Gordish-Dressman, Heather (George Washington University) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
James, Meredith K. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Mayhew, Anna G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Guglieri, Michela (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Fernandez-Torron, Roberto (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Rufibach, Laura E. (The Jain Foundation) ;
Feng, Jia (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Blamire, Andrew (Magnetic Resonance Centre. Translational and Clinical Research Institute. Newcastle University) ;
Carlier, Pierre G. (AIM & CEA NMR Laboratory. Institute of Myology. Pitié-Salpêtrière University Hospital) ;
Spuler, Simone (Charite Muscle Research Unit. Experimental and Clinical Research Center. a Joint Cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W (Stanford University School of Medicine) ;
Jones, Kristi J. (The Children's Hospital at Westmead. and The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (Service des maladies neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Stojkovic, Tanya (Sorbonne Université) ;
Mori-Yoshimura, Madoka (Department of Neurology. National Center Hospital. National Center of Neurology and Psychiatry) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Pegoraro, Elena (University of Padova) ;
Lowes, Linda P (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Mendell, Jerry R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Bushby, Kate (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust)
This study aims to determine clinically relevant phenotypic differences between the two most common phenotypic classifications in dysferlinopathy, limb girdle muscular dystrophy R2 (LGMDR2) and Miyoshi myopathy (MMD1). [...]
2021 - 10.1016/j.nmd.2021.01.009
Neuromuscular Disorders, Vol. 31 Núm. 4 (april 2021) , p. 265-280
|
|
|
5.
|
|
12 p, 2.7 MB |
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
/
Jacobs, M.B. (Pediatrics. Epidemiology. and Biostatistics. George Washington University) ;
James, Meredith K (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Lowes, Linda P (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Alfano, Lindsay N (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Eagle, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Muni Lofra, R. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Moore, U. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Feng, J. (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Rufibach, L.E. (The Jain Foundation) ;
Rose, K. (The Children's Hospital at Westmead. The University of Sydney) ;
Duong, T. (Lucile Salter Packard Children's Hospital at Stanford) ;
Bello, Luca (Department of Neuroscience. University of Padova) ;
Pedrosa-Hernández, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Holsten, Scott (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Sakamoto, C. (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Canal, Aurélie (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Sanchez-Aguilera Práxedes, N. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Thiele, S. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ;
Siener, C. (Department of Neurology Washington University School of Medicine) ;
Vandevelde, B. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
DeWolf, Brittney (Cooperative International Neuromuscular Research Group (CINRG). Children's National Health System) ;
Maron, E. (ELAN-PHYSIO. Praxis für Physiotherapie Maron) ;
Guglieri, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Hogrel, J.Y. (Institut de Myologie (París, França)) ;
Blamire, Andrew (Magnetic Resonance Centre. Institute for Cellular Medicine. Newcastle University) ;
Carlier, Pierre G (AIM & CEA NMR Laboratory. Institute of Myology. Pitié-Salpêtrière University Hospital) ;
Spuler, S. (Charite Muscle Research Unit. Experimental and Clinical Research Center. a joint cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W (Department of Neurology and Neurological Sciences. Stanford University School of Medicine) ;
Jones, K.J. (The Children's Hospital at Westmead. The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, E. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ;
Paradas, C. (Instituto de Biomedicina de Sevilla) ;
Stojkovic, T. (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Pegoraro, Elena (University of Padova) ;
Mendell, J. R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Mayhew, A.G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway)
Objective: Dysferlinopathy is a muscular dystrophy with a highly variable clinical presentation and currently unpredictable progression. This variability and unpredictability presents difficulties for prognostication and clinical trial design. [...]
2021 - 10.1002/ana.26044
Annals of neurology, Vol. 89 Núm. 5 (may 2021) , p. 967-978
|
|
|
6.
|
|
9 p, 1.7 MB |
Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy
/
Moore, Ursula (Newcastle University) ;
Jacobs, Marni (George Washington University) ;
Fernandez-Torron, Roberto (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
LLauger Rossello, Jaume (Institut d'Investigació Biomèdica Sant Pau) ;
Smith, Fiona E. (Newcastle University) ;
James, Meredith K (Newcastle University) ;
Mayhew, Anna (Newcastle University) ;
Rufibach, Laura (Jain Foundation) ;
Carlier, Pierre G. (Université Paris-Saclay) ;
Blamire, Andrew (Newcastle University) ;
Day, John W. (Stanford University) ;
Jones, Kristi J. (The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (Hôpital de La Timone) ;
Pestronk, Alan (Washington University) ;
Walter, Maggie C. (Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Stojkovic, Tanya (Sorbonne Université) ;
Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ;
Bravver, Elena (Carolinas Neuromuscular/ALS-MDA Center) ;
Pegoraro, Elena (University of Padova) ;
Mendell, Jerry R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Bushby, Kate (Newcastle University) ;
Straub, Volker (Newcastle University) ;
Diaz-Manera, Jordi (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Universitat Autònoma de Barcelona
Practice of sports during childhood or adolescence correlates with an earlier onset and more rapidly progressing phenotype in dysferlinopathies. To determine if this correlation relates to greater muscle pathology that persists into adulthood, we investigated the effect of exercise on the degree of muscle fatty replacement measured using muscle MRI. [...]
2020 - 10.3389/fneur.2020.613446
Frontiers in neurology, Vol. 11 (december 2020)
|
|
|
7.
|
|
11 p, 3.9 MB |
Muscle MRI in patients with dysferlinopathy : pattern recognition and implications for clinical trials
/
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Fernandez-Torron, Roberto (MRC Centre for Neuromuscular Diseases) ;
LLauger, Jaume (Institut d'Investigació Biomèdica Sant Pau) ;
James, Meredith K. (MRC Centre for Neuromuscular Diseases) ;
Mayhew, Anna (MRC Centre for Neuromuscular Diseases) ;
Smith, Fiona E. (Newcastle University) ;
Moore, Ursula R. (MRC Centre for Neuromuscular Diseases) ;
Blamire, Andrew (Newcastle University) ;
Carlier, Pierre G. (Pitié-Salpêtrière University Hospital) ;
Rufibach, Laura (The Jain Foundation) ;
Mittal, Plavi (The Jain Foundation) ;
Eagle, Michelle (MRC Centre for Neuromuscular Diseases) ;
Jacobs, Marni (George Washington University) ;
Hodgson, Tim (Newcastle University) ;
Wallace, Dorothy (Newcastle University) ;
Ward, Louise (Newcastle University) ;
Smith, Mark (Nationwide Children's Hospital) ;
Stramare, Roberto (University of Padova) ;
Rampado, Alessandro (University of Padova) ;
Sato, Noriko (National Center Hospital, National Center of Neurology and Psychiatry) ;
Tamaru, Takeshi (National Center Hospital, National Center of Neurology and Psychiatry) ;
Harwick, Bruce (CMC Mercy Charlotte, Carolinas Healthcare System Neurosciences Institute) ;
Rico Gala, Susana (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Turk, Suna (Pitié-Salpêtrière University Hospital) ;
Coppenrath, Eva M. (Ludwig-Maximilians-University) ;
Foster, Glenn (Washington University) ;
Bendahan, David (Aix-Marseille Université) ;
Le Fur, Yann (Aix-Marseille Université) ;
Fricke, Stanley T. (Children's National Health System) ;
Otero, Hansel (Children's National Health System) ;
Foster, Sheryl L. (University of Sydney) ;
Peduto, Anthony (University of Sydney) ;
Sawyer, Anne Marie (Stanford University School of Medicine) ;
Hilsden, Heather (MRC Centre for Neuromuscular Diseases) ;
Lochmuller, Hanns (MRC Centre for Neuromuscular Diseases) ;
Grieben, Ulrike (A Joint Co-operation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Spuler, Simone (A Joint Co-operation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Tesi Rocha, Carolina (Stanford University School of Medicine) ;
Day, John W. (Stanford University School of Medicine) ;
Jones, Kristi J. (Children's Hospital at Westmead, University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (La Timone Hospital, Aix-Marseille Université) ;
Harms, Matthew (Washington University School of Medicine) ;
Pestronk, Alan (Washington University School of Medicine) ;
Krause, Sabine (Ludwig-Maximilians-University of Munich) ;
Schreiber-Katz, Olivia (Ludwig-Maximilians-University of Munich) ;
Walter, Maggie C. (Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Hogrel, J.Y (AP-HP, G.H. Pitié-Salpêtrière) ;
Stojkovic, Tanya (AP-HP, G.H. Pitié-Salpêtrière) ;
Takeda, Shin'ichi (National Center Hospital, National Center of Neurology and Psychiatry) ;
Mori-Yoshimura, Madoka (National Center Hospital, National Center of Neurology and Psychiatry) ;
Bravver, Elena (Carolinas Healthcare System) ;
Sparks, Susan (Carolinas Healthcare System) ;
Bello, Luca (University of Padova) ;
Semplicini, Claudio (University of Padova) ;
Pegoraro, Elena (University of Padova) ;
Mendell, Jerry R. (Nationwide Children's Hospital) ;
Bushby, Kate (MRC Centre for Neuromuscular Diseases) ;
Straub, Volker (MRC Centre for Neuromuscular Diseases) ;
Universitat Autònoma de Barcelona
Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern of muscle involvement in smaller patient cohorts, but a large imaging study across the entire spectrum of the dysferlinopathies had not been performed and previous imaging findings were not correlated with functional tests. [...]
2018 - 10.1136/jnnp-2017-317488
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 89 (may 2018) , p. 1071-1081
|
|
|
8.
|
|
14 p, 396.7 KB |
Assessment of disease progression in dysferlinopathy : A 1-year cohort study
/
Moore, U. (Newcastle University) ;
Jacobs, Marni (George Washington University) ;
James, Meredith K (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Mayhew, Anna G. (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Fernandez-Torron, Roberto (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
Feng, Jia (Center for Translational Science. Division of Biostatistics and Study Methodolog) ;
Cnaan, Avital (GeorgeWashington University) ;
Eagle, Michelle (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Bettinson, Karen (Newcastle University) ;
Rufibach, Laura E. (Jain Foundation) ;
Lofra, Robert M. (Newcastle University) ;
Blamire, Andrew (Newcastle University) ;
Carlier, Pierre G. ;
Mittal, Plavi (Jain Foundation) ;
Lowes, Linda P. (The Ohio State University) ;
Alfano, Lindsay N (The Ohio State University) ;
Rose, Kristy (Institute for Neuroscience andMuscle Research. ChildrensHospital atWestmead. University of Sydney) ;
Duong, Tina (Lucile Salter Packard ChildrensHospital at Stanford) ;
Berry, Katherine M. (Research Institute at Nationwide Childrens Hospital. TheOhio State University) ;
Montiel Morillo, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Pedrosa-Hernández, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Holsten, Scott (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Sanjak, Mohammed (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Ashida, Ai (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Sakamoto, Chikako (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Tateishi, Takayuki (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Yajima, Hiroyuki (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Canal, Aurélie (Institut deMyologie (París, França)) ;
Ollivier, Gwenn (Institut deMyologie (París, França)) ;
Decostre, Valerie (Institut deMyologie (París, França)) ;
Mendez, Juan Bosco (Instituto de Biomedicina de Sevilla) ;
Praxedes, Nieves S. A. (Neurophysiotherapy Department. Hospital Universitario Virgen del Rocacute;io) ;
Thiele, Simone (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Siener, Catherine (Department of Neurology. Washington University School of Medicine) ;
Shierbecker, Jeanine (Department of Neurology. Washington University School of Medicine) ;
Florence, Julaine M. (Cooperative International Neuromuscular Research Group. Department of Neurology) ;
Vandevelde, Bruno (Centre de Reference des Maladies Neuromusculaires PACA Racute;eunion Rhone Alpes. Hopital de la Timone. Aix-Marseille Universitacute;e) ;
DeWolf, Brittney (Cooperative International Neuromuscular Research Group. Department of Neurology) ;
Hutchence, Meghan (Institute for Neuroscience andMuscle Research. ChildrensHospital atWestmead. University of Sydney) ;
Gee, Richard (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Prügel, Juliana (ELAN-PHYSIO. Praxis fur Physiotherapie Maron) ;
Maron, Elke (ELAN-PHYSIO. Praxis fur Physiotherapie Maron) ;
Hilsden, Heather (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Lochmüller, Hanns (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Grieben, Ulrike (ChariteMuscle Research Unit. Experimental and Clinical Research Center. A joint cooperation of the Charitacute;e Medical Faculty) ;
Spuler, Simone (ChariteMuscle Research Unit. Experimental and Clinical Research Center. A joint cooperation of the Charitacute;e Medical Faculty) ;
Rocha, Carolina T. (Department of Neurology and Neurological Sciences. Stanford University School ofMedicine) ;
Day, John W. (Department of Neurology and Neurological Sciences. Stanford University School ofMedicine) ;
Jones, Kristi J. (Institute for Neuroscience andMuscle Research. ChildrensHospital atWestmead. University of Sydney) ;
Bharucha-Goebel, Diana (NIH) ;
Salort-Campana, Emmanuelle (Centre de Reference des Maladies Neuromusculaires PACA Racute;eunion Rhone Alpes. Hopital de la Timone. Aix-Marseille Universitacute;e) ;
Harms, Matthew (Department of Neurology. Washington University School of Medicine) ;
Pestronk, Alan (Department of Neurology. Washington University School of Medicine) ;
Krause, Sabine (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Schreiber-Katz, Olivia (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Walter, Maggie C. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Hogrel, J.Y (Institut de Myologie (París, França)) ;
Stojkovic, Tanya (Institut deMyologie (París, França)) ;
Takeda, Shin'ichi (DepartmentofNeurology. NationalCenterHospital. National Center ofNeurology and Psychiatry) ;
Mori-Yoshimura, Madoka (DepartmentofNeurology. NationalCenterHospital. National Center ofNeurology and Psychiatry) ;
Bravver, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Sparks, Susan (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Manera, Jordi. (Institut d'Investigació Biomèdica Sant Pau) ;
Bello, Luca (Institut d'Investigació Biomèdica Sant Pau) ;
Semplicini, Claudio (Institut d'Investigació Biomèdica Sant Pau) ;
Pegoraro, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Mendell, Jerry R. (The Ohio State University. Research Institute at Nationwide Childrens Hospital) ;
Bushby, Kate (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Straub, Volker (Newcastle University. John Walton Muscular Dystrophy Research Centre) ;
Universitat Autònoma de Barcelona
ObjectiveTo assess the ability of functional measures to detect disease progression in dysferlinopathy over 6 months and 1 year. MethodsOne hundred ninety-three patients with dysferlinopathy were recruited to the Jain Foundation's International Clinical Outcome Study for Dysferlinopathy. [...]
2019 - 10.1212/WNL.0000000000006858
Neurology, Vol. 92 Núm. 5 (29 2019) , p. E461-E474
|
|
|
9.
|
|
27 p, 2.2 MB |
Novel polyomaviruses in mammals from multiple orders and reassessment of polyomavirus evolution and taxonomy
/
Ehlers, Bernhard (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Anoh, A. E. (Université Alassane Ouattara. Centre de Recherche pour le Développement) ;
Salem, N. B. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Broll, S. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Couacy-Hymann, E. (Laboratoire National d'Appui Au Développement Agricole. Laboratoire Central de Pathologie Animale) ;
Fischer, D. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Gedvilaite, A. (Institute of Biotechnology. Vilnius University) ;
Ingenhütt, N. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Liebmann, S. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Martin, Maite (Institut de Recerca i Tecnologia Agroalimentàries. Centre de Recerca en Sanitat Animal) ;
Mossoun, A. (Laboratoire National d'Appui Au Développement Agricole. Laboratoire Central de Pathologie Animale) ;
Mugisha, L. (Makerere University. College of Veterinary Medicine. Animal Resources and Biosecurity (COVAB)) ;
Muyembe-Tamfum, J. J. (Institut National de Recherche Bio-Médicale) ;
Pauly, M. (Robert Koch Institute. Epidemiology of Highly Pathogenic Microorganisms) ;
De Val, B. P. (Institut de Recerca i Tecnologia Agroalimentàries. Centre de Recerca en Sanitat Animal) ;
Preugschas, H. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Richter, D. (Technische Universität Braunschweig) ;
Schubert, G. (Robert Koch Institute. Epidemiology of Highly Pathogenic Microorganisms) ;
Szentiks, C. A. (Leibniz Institute for Zoo and Wildlife Research (IZW)) ;
Teichmann, T. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Walter, C. (Robert Koch Institute. Division 12 Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients) ;
Ulrich, R. G. (Partner Site Hamburg-Lübeck-Borstel-Insel Riems. German Center for Infection Research (DZIF)) ;
Wiersma, L. (Robert Koch Institute. Epidemiology of Highly Pathogenic Microorganisms) ;
Leendertz, F. H. (Robert Koch Institute. Epidemiology of Highly Pathogenic Microorganisms) ;
Calvignac-Spencer, S. (Robert Koch Institute. Viral Evolution)
As the phylogenetic organization of mammalian polyomaviruses is complex and currently incompletely resolved, we aimed at a deeper insight into their evolution by identifying polyomaviruses in host orders and families that have either rarely or not been studied. [...]
2019 - 10.3390/v11100930
Viruses, Vol. 11 Núm. 10 (october 2019) , p. 930
|
|
|
10.
|
|
5 p, 213.1 KB |
Search for coherent charged pion production in neutrino-carbon interactions
/
Hasegawa, M. (16 Kyoto University. Department of Physics) ;
Fernandez, Enrique (Universitat Autònoma de Barcelona. Departament de Física) ;
Aliu i Fusté, Ester (Institut de Física d'Altes Energies) ;
Andringa Dias, Sofia (Institut de Física d'Altes Energies) ;
Aoki, S. (Kobe University (Japó)) ;
Argyriades, J. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Asakura, K. (Kobe University (Japó)) ;
Ashie, R. (University of Tokyo. Institute for Cosmic Ray Research) ;
Berns, H. (University of Washington. Department of Physics) ;
Bhang, H. (Seoul National University. Department of Physics) ;
Blondel, A. (University of Geneva. Section de Physique) ;
Borghi, S. (University of Geneva. Section de Physique) ;
Bouchez, J. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Burguet-Castell, J. (Instituto de Física Corpuscular (València)) ;
Casper, D. (University of California. Department of Physics and Astronomy) ;
Cavata, C. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Cervera, A. (University of Geneva. Section de Physique) ;
Chen, S. M. (TRIUMF (Vancouver, Canadà)) ;
Cho, K. O. (Chonnam National University. Department of Physics) ;
Choi, J. H. (Chonnam National University. Department of Physics) ;
Dore, U. (University of Rome La Sapienza) ;
Espinal Curull, Xavi (Institut de Física d'Altes Energies) ;
Fechner, M. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Fukuda, Y. (Miyagi University of Education. Department of Physics) ;
Gomez-Cadenas, J. (Instituto de Física Corpuscular (València)) ;
Gran, R. (University of Washington. Department of Physics) ;
Hara, T. (Kobe University) ;
Hasegawa, T. (Tohoku University. Research Center for Neutrino Science) ;
Hayashi, K. (Kyoto University. Department of Physics) ;
Hayato, Y. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Helmer, R. L. (TRIUMF (Vancouver, Canadà)) ;
Hill, J. (State University of New York. Department of Physics and Astronomy) ;
Hiraide, K. (Kyoto University. Department of Physics) ;
Hosaka, J. (University of Tokyo. Institute for Cosmic Ray Research) ;
Ichikawa, A. K. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Iinuma, M. (Hiroshima University. Graduate School of Advanced Sciences of Matter) ;
Ikeda, A. (Okayama University. Department of Physics) ;
Inagaki, T. (Kyoto University. Department of Physics) ;
Ishida, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Ishihara, K. (University of Tokyo. Institute for Cosmic Ray Research) ;
Ishii, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Ishitsuka, M. (University of Tokyo. Institute for Cosmic Ray Research) ;
Itow, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
Iwashita, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Jang, H. I. (Chonnam National University. Department of Physics) ;
Jeon, E. J. (Seoul National University. Department of Physics) ;
Jeong, I. S. (Chonnam National University. Department of Physics) ;
Joo, K. K. (Seoul National University. Department of Physics) ;
Jover Mañas, Gabriel Vicent (Institut de Física d'Altes Energies) ;
Jung, C. K. (State University of New York. Department of Physics and Astronomy) ;
Kajita, T. (University of Tokyo. Institute for Cosmic Ray Research) ;
Kameda, J. (University of Tokyo. Institute for Cosmic Ray Research) ;
Kaneyuki, K. (University of Tokyo. Institute for Cosmic Ray Research) ;
Kato, I. (TRIUMF (Vancouver, Canadà)) ;
Kearns, E. (Boston University. Department of Physics) ;
Kerr, D. (State University of New York. Department of Physics and Astronomy) ;
Khabibullin, M. (Institute for Nuclear Research (Moscou, Rússia)) ;
Khotjantsev, A. (Institute for Nuclear Research (Moscou, Rússia)) ;
Kielczewska, D. (A. Soltan Institute for Nuclear Studies (Varsòvia, Polònia)) ;
Kim, C. O. (Korea University. Department of Physics) ;
Kim, J. Y. (Chonnam National University. Department of Physics) ;
Kim, S. B. (Seoul National University. Department of Physics) ;
Kitching, P. (TRIUMF (Vancouver, Canadà)) ;
Kobayashi, K. (State University of New York. Department of Physics and Astronomy) ;
Kobayashi, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Konaka, A. (TRIUMF (Vancouver, Canadà)) ;
Koshio, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
Kropp, W. (University of California. Department of Physics and Astronomy) ;
Kubota, J. (Kyoto University. Department of Physics) ;
Kudenko, Yu. (Institute for Nuclear Research (Moscou, Rússia)) ;
Kuno, Y. (Osaka University. Department of Physics) ;
Kutter, T. (University of British Columbia. Department of Physics and Astronomy) ;
Learned, J. (University of Hawaii. Department of Physics and Astronomy) ;
Likhoded, S. (Boston University. Department of Physics) ;
Lim, I. T. (Chonnam National University. Department of Physics) ;
Loverre, P. F. (University of Rome La Sapienza) ;
Ludovici, L. (University of Rome La Sapienza) ;
Maesaka, H. (Kyoto University. Department of Physics) ;
Mallet, J. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Mariani, C. (University of Rome La Sapienza) ;
Maruyama, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Matsuno, S. (University of Hawaii. Department of Physics and Astronomy) ;
Matveev, V. (Institute for Nuclear Research (Moscou, Rússia)) ;
Mauger, C. (State University of New York. Department of Physics and Astronomy) ;
McConnel Mahn, Kendall Brianna (Massachusetts Institute of Technology. Department of Physics) ;
McGrew, C. (State University of New York. Department of Physics and Astronomy) ;
Mikheyev, S. (Institute for Nuclear Research (Moscou, Rússia)) ;
Minamino, A. (University of Tokyo. Institute for Cosmic Ray Research) ;
Mine, S. (University of California. Department of Physics and Astronomy) ;
Mineev, O. (Institute for Nuclear Research (Moscou, Rússia)) ;
Mitsuda, C. (University of Tokyo. Institute for Cosmic Ray Research) ;
Miura, M. (University of Tokyo. Institute for Cosmic Ray Research) ;
Moriguchi, Y. (Kobe University) ;
Morita, T. (Kyoto University. Department of Physics) ;
Moriyama, S. (University of Tokyo. Institute for Cosmic Ray Research) ;
Nakadaira, T. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Nakahata, M. (University of Tokyo. Institute for Cosmic Ray Research) ;
Nakamura, K. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Nakano, I. (Okayama University. Department of Physics) ;
Nakaya, T. (Kyoto University. Department of Physics) ;
Nakayama, S. (University of Tokyo. Institute for Cosmic Ray Research) ;
Namba, T. (University of Tokyo. Institute for Cosmic Ray Research) ;
Nambu, R. (University of Tokyo. Institute for Cosmic Ray Research) ;
Nawang, S. (Hiroshima University. Graduate School of Advanced Sciences of Matter) ;
Nishikawa, K. (Kyoto University. Department of Physics) ;
Nitta, K. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Nova, Federico (Institut de Física d'Altes Energies) ;
Novella, P. (Instituto de Física Corpuscular (València)) ;
Obayashi, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
Okada, A. (University of Tokyo. Institute for Cosmic Ray Research) ;
Okumura, K. (University of Tokyo. Institute for Cosmic Ray Research) ;
Oser, S. M. (University of British Columbia. Department of Physics and Astronomy) ;
Oyama, Y. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Pac, M. Y. (Dongshin University. Department of Physics) ;
Pierre, F. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Rodríguez Marrero, Ana Yaiza (Institut de Física d'Altes Energies) ;
Saji, C. (University of Tokyo. Institute for Cosmic Ray Research) ;
Sakuda, M. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Sánchez Nieto, Federico (Institut de Física d'Altes Energies) ;
Sarrat, A. (State University of New York. Department of Physics and Astronomy) ;
Sasaki, T. (Kyoto University. Department of Physics) ;
Sato, H. (Kyoto University. Department of Physics) ;
Scholberg, K. (Duke University. Department of Physics) ;
Schroeter, R. (University of Geneva. Section de Physique) ;
Sekiguchi, M. (Kobe University) ;
Sharkey, E. (State University of New York. Department of Physics and Astronomy) ;
Shiozawa, M. (University of Tokyo. Institute for Cosmic Ray Research) ;
Shiraishi, K. (University of Washington. Department of Physics) ;
Sitjes, G. (Instituto de Física Corpuscular (València)) ;
Smy, M. (University of California. Department of Physics and Astronomy) ;
Sobel, H. (University of California. Department of Physics and Astronomy) ;
Stone, J. (Boston University. Department of Physics) ;
Sulak, L. (Boston University. Department of Physics) ;
Suzuki, A. (Kobe University) ;
Suzuki, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
T'Jampens, S. (Commissariat à l'Énergie Atomique et aux Énergies Alternatives (França)) ;
Takahashi, T. (Hiroshima University. Graduate School of Advanced Sciences of Matter) ;
Takenaga, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
Takeuchi, Y. (University of Tokyo. Institute for Cosmic Ray Research) ;
Taki, K. (University of Tokyo. Institute for Cosmic Ray Research) ;
Takubo, Y. (Osaka University. Department of Physics) ;
Tamura, N. (Niigata University. Department of Physics) ;
Tanaka, M. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Terri, R. (State University of New York. Department of Physics and Astronomy) ;
Tornero-Lopez, A. (Instituto de Física Corpuscular (València)) ;
Totsuka, Y. (High Energy Accelerator Research Organization (KEK) (Japó)) ;
Ueda, S. (Kyoto University. Department of Physics) ;
Vagins, M. (University of California. Department of Physics and Astronomy) ;
Walter, C. W. (Duke University. Department of Physics) ;
Wang, W. (Boston University. Department of Physics) ;
Whitehead, L. (State University of New York. Department of Physics and Astronomy) ;
Wilkes, R. J. (University of Washington. Department of Physics) ;
Yamada, S. (University of Tokyo. Institute for Cosmic Ray Research) ;
Yamamoto, S. (Kyoto University. Department of Physics) ;
Yanagisawa, C. (State University of New York. Department of Physics and Astronomy) ;
Yershov, N. (Institute for Nuclear Research (Moscou, Rússia)) ;
Yokoyama, H. (Tokyo University . Department of Physics) ;
Yokoyama, M. (Kyoto University. Department of Physics) ;
Yoo, J. (Seoul National University. Department of Physics) ;
Yoshida, M. (Osaka University. Department of Physics) ;
Zalipska, J. (A. Soltan Institute for Nuclear Studies (Varsòvia, Polònia)) ;
K2K Collaboration ;
American Physical Society
We report the result from a search for charged-current coherent pion production induced by muon neutrinos with a mean energy of 1. 3 GeV. The data are collected with a fully active scintillator detector in the K2K long-baseline neutrino oscillation experiment. [...]
2005 - 10.1103/PhysRevLett.95.252301
Physical review letters, Vol. 95, Issue 25 (December 2005) , p. 252301-1-252301-5
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
